VELOXIS PHARMACEUTICALS A/S — Credit Rating and Financial Key Figures

VELOXIS PHARMACEUTICALS A/S (CVR number: 26527767) is a company from KØBENHAVN. The company reported a net sales of 16.6 mUSD in 2018, demonstrating a growth of 30.9 % compared to the previous year. The operating profit percentage was at 81.1 % (EBIT: 13.5 mUSD), while net earnings were 19.5 mUSD. The profitability of the company measured by Return on Assets (ROA) was 17.4 %, which can be considered excellent and Return on Equity (ROE) was 31.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 98.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. VELOXIS PHARMACEUTICALS A/S's liquidity measured by quick ratio was 1.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.